Refine
Year of publication
Language
- English (51)
Has Fulltext
- yes (51)
Is part of the Bibliography
- no (51)
Keywords
- BESIII (6)
- Branching fractions (3)
- Hadronic decays (3)
- COVID-19 surveillance (2)
- Charmonium (2)
- Cross section (2)
- Omicron (2)
- SARS-CoV-2 monitoring (2)
- Acute Myeloid Leukemia (1)
- Angular distribution (1)
- Annihilation (1)
- Anticoagulation (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- Bhabha (1)
- Branching fraction (1)
- COVID-19 (1)
- Cross section measurements (1)
- D meson (1)
- D0 and D+ mesons (1)
- Dalitz decay (1)
- Detection workflow (1)
- D⁰ meson (1)
- Electromagnetic form factor (1)
- Experimental autoimmune encephalomyelitis (1)
- Hadronic cross section (1)
- Hadrons (1)
- Inflammation (1)
- Initial state radiation (1)
- Iron Overload (1)
- Iron chelation (1)
- Mice (1)
- Muon anomaly (1)
- NMR spectroscopy (1)
- Pharmacodynamics (1)
- Pion form factor (1)
- R value (1)
- SARS-CoV-2 (1)
- Target validation (1)
- Triple quarkonia (1)
- Variant of concern (1)
- Wastewater-based epidemiology (WBE) (1)
- Y (4260) (1)
- accessory proteins (1)
- asparaginyl endopepdidase (AEP) (1)
- cell-free protein synthesis (1)
- chronic hypoxia (1)
- diphoton (1)
- e+e− annihilation (1)
- ectosomes (1)
- exosomes (1)
- extracellular vesicles (1)
- glycolysis (1)
- guidelines (1)
- intrinsically disordered region (1)
- legumain (1)
- luminosity (1)
- microenvironment (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- multiple myeloma (1)
- multiple sclerosis (1)
- myelodysplastic syndrome (1)
- nonstructural proteins (1)
- radical oxygen species (1)
- reproducibility (1)
- rigor (1)
- standardization (1)
- structural proteins (1)
- variant of concern (1)
- wastewater-based epidemiology (WBE) (1)
- Σ hyperon (1)
Institute
Background and Objectives: Proteins of the coagulation system contribute to autoimmune inflammation in patients with multiple sclerosis (MS). On blood-brain barrier (BBB) disruption, fibrinogen enters the CNS and is rapidly converted to fibrin, unfolding pleiotropic autoimmune mechanisms. Fibrin accumulation leads to subsequent proteolytic degradation that results in D-dimer generation. The primary objective of this study was to determine intrathecal levels of D-dimer in CSF as a measure of intrathecal coagulation cascade activation and to evaluate its diagnostic utility in patients with MS in contrast to healthy subjects. Key secondary objectives included analysis of CSF D-dimer in differential diagnoses of MS and its relation to routine clinical markers of disease activity.
Methods: Patients admitted for the assessment of suspected MS were prospectively recruited from October 2017 to December 2020. Blood plasma and citrated CSF samples were analyzed using a highly sensitive luminescent oxygen channeling immunoassay. Intrathecal generation of D-dimer was analyzed by adjusting for CSF/serum albumin (Qalb) and CSF/plasma D-dimer quotients (QD-dimer), and corresponding CSF fibrinogen levels were determined. Final diagnoses after full evaluation and clinical data were recorded.
Results: Of 187 patients, 113 patients received a diagnosis of MS or clinically/radiologically isolated syndrome. We found increased intrathecal CSF D-dimer generation levels (QD-dimer/Qalb-index) for patients with relapsing-remitting MS (RRMS; n = 71, median 4.7, interquartile range [IQR] 2.5–8.0) when compared with those for disease controls (n = 22, median 2.6, IQR 2.1–4.8, p = 0.031). Absolute CSF D-dimer values correlated with CSF fibrinogen levels (r = 0.463; p < 0 .001) and CSF leukocytes (r = 0.273; p = 0.003) and were elevated in MS patients with contrast enhancement (CE) compared with MS patients without CE on MRI (n = 48, median 6 ng/mL, and IQR 3–15.25 vs n = 41, median 4 ng/mL, and IQR 2–7; p = 0.026). Exploratory subgroup analyses indicated a correlation of intrathecal inflammatory activity and CSF D-dimer levels.
Discussion: D-dimer in CSF can be reliably determined and correlates with markers of CNS inflammation and CSF fibrinogen levels. Adjusted for BBB dysfunction, CSF D-dimer may allow the identification of intrathecal coagulation cascade activation in patients with MS.
Classification of Evidence: This study provides Class I evidence that CSF D-dimer levels are elevated in patients with RRMS.